Robitussin cough syrup supplied nationally is being recalled by Haleon owing to microbial contamination that may cause fatal infections in susceptible individuals, the US division of the global consumer health company based in the UK announced this week.
"Use of the recalled products could potentially result in severe or life-threatening fungal infections in those with impaired immune systems," Haleon stated in a notice posted by the Food and Drug Administration, according to CBS.
"Most users are unlikely to experience a serious health problem, but an infection that requiring medical intervention can't be ruled out," the company said.
Robitussin is frequently used to treat respiratory allergies, the common cold, the flu, and hay fever. The following goods are included in the recall, along with their lot numbers and expiration dates:
Robitussin Honey CF Max Day Adult 4oz — T10810 — October 31, 2025
Robitussin Honey CF Max Day Adult 8oz — T08730, T08731, T08732, T08733 — May 31, 2025
Robitussin Honey CF Max Day Adult 8oz — T10808 — September 30, 2025
Robitussin Honey CF Max NT Adult 8oz — T08740, T08742 — June 30, 2026
"Consumers who purchased the recalled products shouldn't use them," Haleon said.
"Concerns over politics may be prompting today's pressure at the PSX," says analyst
Children face risks of mental health as result of using electronic devices, as per new study
Fares for all freight, goods trains to surge by 2% increase
Responding to Leghari, ex-minister Ejaz claims IPP contracts burdened public with Rs200bn worth of payments
Political risks may jeopardise enforcement of prescribed measures, says rating agency
Experts fear high circulation could make it easier for a mutation of virus to develop that would allow it to pass on
